196 Embryo production using follicle-stimulating hormone (FSH) or FSH+equine chorionic gonadotropin in beef donors

The objective of the present study was to evaluate the superovulatory response and embryo production in beef donors using 8 twice-daily injections of FSH or an alternative protocol in which the last 4 FSH injections were replaced with a single injection of eCG. In Exp. 1, 12 mature Bonsmara donor cows, with a body condition score between 3 and 4 (1 to 5 scale) were superstimulated twice every 46 days in a crossover design (i.e. in each experiment all cows received 2 treatments and the 2 treatments were equally represented in each replicate). On Day 0 a.m., all donors received an intravaginal device with 1.2g of progesterone (Diprogest 1200®, Zoovet, Santa Fe, Argentina), along with 50mg of progesterone i.m (Progestar®, Zoetis, Buenos Aires, Argentina) and 5mg of oestradiol-17β (17βOestradiol®, Rio de Janeiro, Argentina) IM. On Day 4 a.m., the superstimulatory treatments were initiated and donors in the control group received 8 applications of FSH (Folltropin-V, Vetoquinol, Lure, France), IM (total dose: 300mg NIH-FSH-P1) in a twice-daily decreasing dosage schedule over 4 days (i.e. 60, 60, 50, 50, 30, 30, 10, and 10mg, respectively). Donors in the FSH+800 eCG group received only the first 4 applications of FSH (i.e. 60, 60, 50 and 50mg, respectively) and on Day 6 a.m. they received 800IU of eCG (Novormón®, Zoetis) IM in a single dose. All donors received 500μg of cloprostenol (Ciclase DL®, Zoetis) IM on Day 6 a.m. and p.m., and the intravaginal devices were removed on Day 7 a.m. All cows also received 100μg of gonadorelin acetate (GnRH, Gonasyn gdr, Zoetis) on Day 8 a.m. and were inseminated with frozen-thawed semen from 2 bulls 12 and 24h later. On Day 15, ova/embryos were collected and evaluated according to the IETS standards. The data were analysed by GLMM (Infostat, 2018). In Exp 2., 18 Bonsmara donors with similar conditions as those in Exp. 1 were superovulated twice in a crossover design. Cows in both groups received similar treatments to those in the FSH+eCG treatment of Exp. 1, except that the total dosage of FSH was 200mg (i.e. 60, 60, 40, and 40mg, respectively) and the eCG given on Day 6 a.m. was either 600IU (group 1) or 800IU (group 2). In Exp 1., the FSH (control) group had a higher (P<0.01) number of fertilized oocytes, but there were no differences in the other end points evaluated (Table 1). In Exp. 2, no differences were found between FSH+800 eCG and FSH+600 eCG groups in any of the parameters evaluated. In conclusion, the replacement of the last 4 injections of FSH by a single dose of eCG decreases the number of treatments required in a superovulation program without negatively affecting the production of transferable embryos. Table 1.Embryo production (means±s.e.m.) in Bonsmara donors treated with FSH or FSH+eCG

Peripheral and central analgesic activity evaluation of ethanolic extract of Vitex Negundo flowers in experimental animals

Background: Vitex negundo Linn (Family: Verbenaceae), locally known as ‘Nirgundi’ an important medicinal plant is a woody, aromatic shrub growing to a small tree. It commonly bears tri- or penta-foliate leaves on quadrangular branches, which give rise to bluish-purple coloured flowers in branched tomentose cymes. It has been claimed to possess analgesic activity apart from many medicinal properties. The aim of the present study was to evaluate both the peripheral and central analgesic activity of ethanolic extract of Vitex negundo flowers (EEVNF) in experimental animals.Methods: Acute toxicity test was done following the Organization of Economic Cooperation and Development guidelines. EEVNF (100mg/kg, 200mg/kg, and 400 mg/kg body weight [b.w.] p.o) was evaluated for peripheral analgesic activity by the acetic acid (0.7%) induced writhing test and central analgesic activity by the tail flick method respectively using aspirin (100mg/kg b.w. and 300mg/kg b.w.) as the standard drug.Results: EEVNF significantly decreased the number of writhing in writhing test at all the doses (p<0.001) and increased the reaction time in tail-flick method (p<0.001) at all the doses when compared to control. EEVNF in the dosage of 400mg/kg b.w. produced analgesic effects which was comparable with that of the standard drug aspirin at dose 100mg/kg b.w in writhing test and produced greater analgesic activity than that of standard drug aspirin at dose 300mg/kg b.w in tail flick method.Conclusions: EEVNF has significant peripheral and central analgesic activity.